Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity.
about
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsLipid and glycolipid antigens of CD1d-restricted natural killer T cells.Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsCD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy.Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.CD1 Antigen Presentation and Autoreactivity in the Pregnant Human Uterus.Immunoproteomic identification of bovine pericardium xenoantigensCD1 mediated T cell recognition of glycolipids.Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3.Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.Optimizing NKT cell ligands as vaccine adjuvantsStrategies for desymmetrising trehalose to synthesise trehalose glycolipids.Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function.Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells.Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.The equine CD1 gene family is the largest and most diverse yet identified.
P2860
Q26748456-5C20AD66-7A3A-438E-8710-EC24DA2CA674Q33724575-D42F81CE-0111-4B68-8C52-8572F84530D2Q33778356-9E3A0139-2442-4BEF-A2D9-C1E6E0197E0AQ34130740-FDA19761-DCBD-487B-8801-8896054CBA8CQ35637379-869DED9F-28E5-486E-A048-351284969130Q35832587-3731EF45-0357-42AF-8E01-E8B0E50F7602Q36841930-953291A8-1521-42C8-A68E-EA3B72C13D02Q36976919-293B2023-6739-4E92-863A-017EBD886DCFQ37083114-8CBEDD5E-0C66-45A5-8767-223B7E179478Q37286356-7AD4ADFE-B5AA-4EC7-B168-0EBEDCFAE153Q37534913-7AE99FBD-BB04-42B5-819D-34C51DDED28AQ38206819-C24808D8-DBA5-442C-BBC9-7C7BEF5028BDQ38222271-226FB525-2BEE-4E42-96A3-753BC429521CQ39379034-A76CDB6C-ACE7-45FD-8AFE-472A8204D495Q39384289-E7FEE2F0-535E-4527-A768-89893BE0AFC9Q41882089-EBC15619-E76E-49AA-AFC2-0393A8536F9AQ42550338-6438101A-5AC9-4F01-8528-01A15859033DQ42966143-A26867C2-2E50-411C-8958-48093EB778ACQ45012497-12C7B9B6-93DB-483B-AC56-2E856024BDFA
P2860
Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@ast
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@en
type
label
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@ast
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@en
prefLabel
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@ast
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@en
P1476
Antigen presentation by CD1 mo ...... ipid-specific T cell immunity.
@en
P2093
Porcelli SA
P2888
P304
P356
10.1007/S00018-007-7007-0
P577
2007-07-01T00:00:00Z